Search Result "amg 548"
MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein
Journal: Current Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2005 Page: 2979-2994
Author(s): Matthew R. Lee, Celia Dominguez
Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 1 Year: 2005 Page: 1017-1029
Author(s): David M. Goldstein, Tobias Gabriel
Safety of Multi-Targeted Kinase Inhibitors as Monotherapy Treatment of Cancer: A Systematic Review of the Literature
Journal: Current Drug Safety
Volume: 4 Issue: 2 Year: 2009 Page: 143-154
Author(s): Sheila Crean, Dylan M. Boyd, Brian Sercus, Michael Lahn
New Therapies in SLE
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 2 Issue: 1 Year: 2008 Page: 11-23
Author(s): Antonio La Cava, Francesca Ferrera, Gilberto Filaci, Marta Rizzi, Ram P. Singh, Francesco Indiveri, Bevra H. Hahn
TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1 Issue: 1 Year: 2006 Page: 65-76
Author(s): Louise A. Roberts, Mark Connor
The Endeavours in RAS Inhibition - the Past, Present, and Future
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 29 Year: 2020 Page: 2708-2722
Author(s): Javeena Hussain,Sivapriya Kirubakaran,Srimadhavi Ravi
Novel MK2 Inhibitors by Fragment Screening
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 12 Issue: 7 Year: 2009 Page: 697-703
Author(s): Oliver Keminer, Joachim Kraemer, Jan Kahmann, Ina Sternberger, Christoph Scheich, Joern Jungmann, Sabine Schaertl, Dirk Winkler, Osamu Ichihara, Mark Whittaker, Dirk Ullmann, Thomas Hesterkamp
p38 MAPK: A Potential Target of Chronic Pain
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 38 Year: 2014 Page: 4405-4418
Author(s): X. Lin,M. Wang,J. Zhang,R. Xu
TRPV1: On the Road to Pain Relief
Journal: Current Molecular Pharmacology
Volume: 1 Issue: 3 Year: 2008 Page: 255-269
Author(s): Andres Jara-Oseguera, Sidney A. Simon, Tamara Rosenbaum
Bevacizumab for Glioblastoma Treatment: Reviewing Biological and Clinical Hypothesis for its Success and Failures
Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 3 Year: 2016
Author(s): Ana C. Fernandes,Cláudia Caeiro,Vera Miranda-Gonçalves,Fernanda Cury,Margarida Damasceno,Rui M. Reis,Olga Martinho
Doi: 10.2174/9781681081557116030007